Chemotherapy of malignant tumors is extremely problematic because of the low selectivity of the available cytostatic agents. The now synthetically available ether 2—the first stable analogue of lactone 1, which was identified as the tumor-associated antigen—presents the possibility for an active immunization against cancer.
No takes yet. Share an insight, caveat, or question.
Tietze et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: